Intratumoral Injection of Lipopolysaccharide Causes Regression of Subcutaneously Implanted Mouse Glioblastoma Multiforme
Author:
Affiliation:
1. Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Clinical Neurology,Surgery
Link
http://academic.oup.com/neurosurgery/article-pdf/48/3/607/24477415/00006123-200103000-00032.pdf
Reference39 articles.
1. Antitumor effect of DT-5461a, a synthetic low-toxicity lipid A analog, involves endogenous tumor necrosis factor induction subsequent to macrophage activation;Akimoto;Int J Immunopharmacol,1994
2. DT-5461a, an antitumor synthetic lipid A analog, causes selective blood flow reduction in tumor tissue;Akimoto;Anticancer Res,1995
3. Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity;Ben-Nathan;J Med Microbiol,1999
4. Long-term remission of malignant brain tumors after intracranial infection: A report of four cases;Bowles;Neurosurgery,1999
5. Lymphocyte trafficking and regional immunity: A review;Butcher;Adv Immunol,1999
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sphinganine recruits TLR4 adaptors in macrophages and promotes inflammation in murine models of sepsis and melanoma;Nature Communications;2024-07-18
2. Intra-tumoral immunomodulatory therapy for advanced abdominal cancers using lipopolysaccharide: The Regional Immuno-Oncology Trial-1 (RIOT-1) protocol (NCT05751837);Surgical Oncology Insight;2024-06
3. Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas;Seminars in Radiation Oncology;2024-04
4. Exploring the gut microbiota and its potential as a biomarker in gliomas;Biomedicine & Pharmacotherapy;2024-04
5. Lipopolysaccharide induces CCL2 through TLR4 signaling and promotes esophageal squamous cell carcinoma cell proliferation;American Journal of Cancer Research;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3